# Lantheus Holdings, Inc. – Consensus ‘strong_buy’ rating and 47.3% Upside Potential

- Link: https://www.directorstalkinterviews.com/lantheus-holdings-inc-consensus-strong-buy-rating-and-47-3-upside-potential/4121184454
- Published: 2025-01-22T13:24:29+00:00
- Author: Charlotte Edwards

**Lantheus Holdings, Inc.** which can be found using ticker (LNTH) now have 13 confirmed
analysts covering the stock with the consensus suggesting a rating of ‘strong_buy’.
The range between the high target price and low target price is between $166.00 
and $110.00 suggesting an average Analsyt target price of $134.69. Given that the
stocks previous close was at $91.47 this now indicates there is a potential upside
of 47.3%. There is a 50 day moving average of $89.64 while the 200 day moving average
is $92.22. The company has a market capitalization of 6.54B. Currently the stock
stands at: $94.05 USD

 The potential market cap would be $9,628,865,990 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 15.62, revenue per share of $21.69
and a 17% return on assets.

Lantheus Holdings, Inc. is an integrated provider of imaging diagnostics, targeted
therapeutics, and artificial intelligence solutions to find, fight and follow serious
medical conditions. The Company’s products include precision diagnostics, radiopharmaceutical
oncology, and strategic partnerships. Its precision diagnostic products assist healthcare
professionals (HCPs) Find and Follow diseases, with a focus on cardiology. Its radiopharmaceutical
oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Its
strategic partnerships focus on enabling precision medicine through the use of biomarkers,
digital solutions and pharma services platforms, and also includes the Company’s
license of RELISTOR to Bausch Health Companies, Inc. (Bausch). Its commercial products
are used by oncologists, urologists, nuclear medicine physicians, cardiologists,
sonographers, technologists, radiologists, and internal medicine physicians working
in a variety of clinical settings.

Share on:
